A landmark 2000 study claiming glyphosate in Roundup was safe has been retracted due to ethical concerns and industry influence, renewing fears about the herbicide's carcinogenic potential and prompting calls for regulatory reassessment by the EPA.
A long-term study on Sprague–Dawley rats found that exposure to glyphosate and glyphosate-based herbicides at levels similar to EU safety limits increased the incidence of multiple benign and malignant tumors, including leukemia, skin, liver, thyroid, and nerve tumors, supporting the classification of glyphosate as a probable carcinogen based on experimental evidence.
A study by Arizona State University and TGen reveals that even low levels of glyphosate, a common herbicide, can lead to brain inflammation and cognitive decline in mice, raising concerns about its long-term safety. The research highlights the potential risks of glyphosate exposure, particularly in agricultural settings, and its association with neurodegenerative diseases like Alzheimer's. The findings suggest a need for stricter monitoring and further research to assess the public health impact and explore safer alternatives.
A recent study suggests that even low levels of glyphosate, a common pesticide found in foods like cereals and orange juice, may cause Alzheimer's-like symptoms in mice. The research indicates that glyphosate can lead to brain inflammation and nerve decay, potentially contributing to cognitive decline. While the study was conducted on mice, it raises concerns about the long-term safety of glyphosate exposure in humans, highlighting the need for further investigation into environmental factors affecting brain health.
A study from Arizona State University reveals that glyphosate, a common herbicide, can cause long-term brain inflammation and accelerate Alzheimer's-like symptoms in mice, even after short-term exposure. The research highlights the accumulation of glyphosate's metabolite in brain tissue, raising concerns about its safety for humans and its potential role in neurodegenerative diseases. These findings challenge the perceived safety of glyphosate and underscore the need for further investigation into its health impacts.
A study by Arizona State University researchers reveals that even brief exposure to glyphosate, a common herbicide, can cause lasting brain damage, including neuroinflammation and Alzheimer's-like symptoms. The research, published in the Journal of Neuroinflammation, highlights the potential risks of glyphosate, especially in rural areas with high exposure due to farming. The findings suggest a need to reassess the safety of glyphosate and other environmental toxins, as current regulations may underestimate their long-term impact on brain health.
A Philadelphia jury awarded a $2.25 billion verdict to a man who claimed his non-Hodgkin’s lymphoma was caused by Bayer's Roundup weed killer, with $2 billion in punitive damages. Bayer plans to appeal the verdict, stating that its products can be used safely and are not carcinogenic. This is the latest in a series of lawsuits against the company, with previous awards including $332 million and $175 million. The World Health Organization suggested in 2015 that glyphosate, the key ingredient in Roundup, is "probably carcinogenic to humans," but the U.S. Environmental Protection Agency later stated that there are no risks of concern to human health when glyphosate is used according to its current label.
Bayer's shares fell nearly 6% after a court ordered the company to pay $2.25 billion in damages to a man who claimed he developed cancer from exposure to its Roundup weedkiller. The verdict poses a significant challenge for CEO Bill Anderson, who is already dealing with management cuts and a review of the company's structure. Bayer, burdened by financial debt and lack of free cash flow, remains committed to taking cases to trial despite the ongoing litigation related to glyphosate.
Juries have awarded plaintiffs over $2 billion in damages in recent cases related to Roundup, the weedkiller produced by Bayer's subsidiary Monsanto, which has been linked to cancer. Despite a $10 billion settlement in 2020, Bayer continues to face lawsuits and has set aside an additional $6 billion to cover pending and potential future cases. Shareholders are pressuring the company to make structural changes, and Bayer's market capitalization has dropped to less than half of what it paid for Monsanto. The company insists that Roundup is safe and non-carcinogenic, but plaintiffs' lawyers are building stronger cases over time. Bayer's determination to fight the lawsuits highlights the importance of Roundup to its business, as most of its crop sciences sales come from the herbicide.
Weedkiller brand Roundup, owned by Bayer, has been ordered to pay over $1.56 billion in damages to three gardeners who claimed that the product caused them to develop non-Hodgkin's lymphoma. The verdict marks the fourth consecutive legal loss for Bayer, which acquired Roundup as part of its purchase of Monsanto. The plaintiffs alleged that glyphosate, the active chemical in Roundup, was responsible for their cancer, although scientists are divided on its carcinogenic properties. This ruling could increase pressure on Bayer to change its legal strategy and appeal the verdicts. Over 165,000 people have filed personal injury claims against Roundup, with thousands more expected to follow.
Bayer has been ordered by a Missouri jury to pay $1.56 billion to four plaintiffs who claimed that the company's Roundup weedkiller caused them injuries, including cancer. The jury found that Bayer's Monsanto business was liable for negligence, design defects, and failing to warn plaintiffs about the potential dangers of using Roundup. The verdict marks the fourth consecutive loss for Bayer in court and could increase investor pressure on the company to change its legal strategy. Bayer has stated that Roundup and its active ingredient, glyphosate, are safe for human use and intends to appeal the recent verdict.
The European Union has decided to extend the authorization of glyphosate, the controversial active ingredient in Bayer AG's Roundup weedkiller, for 10 years, despite the lack of agreement among member states. While the World Health Organization's cancer research agency concluded in 2015 that glyphosate was probably carcinogenic to humans, other agencies, including the US Environmental Protection Agency and EU agencies, have classified it as non-carcinogenic. The decision has been condemned by environmental groups, such as Greenpeace, who argue that glyphosate has negative effects on human health and the environment.
A California jury has awarded $332 million to a man who claimed that Monsanto's weedkiller Roundup caused his cancer. The man, Mike Dennis, was diagnosed with non-Hodgkin's lymphoma in 2020 and alleged that his cancer was a result of using Roundup for decades. The jury found that Monsanto failed to warn consumers of Roundup's risks and awarded Dennis $7 million in compensatory damages and $325 million in punitive damages. Bayer, the parent company of Monsanto, plans to appeal the verdict.
A study published in the journal PNAS has found a link between soy farming and an increase in child cancer deaths in Brazil, the world's largest producer and exporter of soybeans. The study suggests that agricultural pesticide exposure, including the widely used weedkiller glyphosate, is associated with higher childhood cancer mortality rates. The researchers found a correlation between soy production and childhood blood cancers, particularly acute lymphoblastic leukemia (ALL). The expansion of soybean production in Brazil was linked to an additional 123 deaths of children under the age of 10 from ALL between 2008 and 2019. The researchers speculate that increased pesticide use may be contaminating water supplies near soy farms.
A field study conducted by researchers at Duke University has found a possible link between glyphosate, the active compound in Roundup herbicide, and epidemic levels of chronic kidney disease in rural Sri Lanka. The study suggests that glyphosate may interact with hard water, forming complexes that persist for years and potentially contribute to kidney damage. Elevated levels of glyphosate were found in 44% of wells within affected areas compared to 8% outside. The researchers also discovered elevated levels of fluoride and vanadium, which are linked to kidney damage. The findings highlight the need for further investigation into the risks of glyphosate exposure and water contamination.